Astera Labs, Inc. ALAB
364.62
4.11
1.14%
as of 25 Sep
- Market cap
- $63.7B
- P/E
- 168×
Follow ALAB
Growth Flags
show if company had growth for consecutive years
| Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 126.99 |
P/S ratio |
19.89 | 19.89 | 43.87 | 32.47 |
P/FCF ratio |
0.00 | 0.00 | 169.73 | 98.25 |
P/Operating CF |
159.96 | 159.96 | 437.89 | 290.60 |
P/B ratio |
0.00 | 0.00 | 18.02 | 20.30 |
Price to Tangible BV |
0.00 | 0.00 | 18.02 | 20.59 |
EV/Sales |
18.60 | 18.60 | 41.56 | 31.08 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 153.75 |
EV/Operating CF |
(169.39) | (169.39) | 120.51 | 82.98 |
EV/FCF |
(139.17) | (139.17) | 160.80 | 94.03 |
Quick Ratio |
4.34 | 4.49 | 11.01 | 9.56 |
Current Ratio |
5.14 | 5.30 | 11.71 | 10.24 |
Net Debt/EBITDA |
2.72 | 5.08 | 7.53 | (6.90) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.57 | 0.63 | 0.66 |
Operating CF/Net income |
0.62 | 0.48 | (1.64) | 1.46 |
Capex/Depreciation |
(13.73) | (22.45) | 6.48 | 34.04 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 |
| 0.00% | 28.70% | (19.24%) | 18.82% | |
| 0.00% | (12.87%) | (13.34%) | 16.95% | |
ROIC |
0.00% | 0.00% | (143.65%) | 62.00% |
Return on Tangible Assets |
(34.43%) | (16.89%) | (8.67%) | 16.59% |
Average Days of Receivables |
48.99 | 26.27 | 35.75 | 35.62 |
Research and Development Expense of Revenue |
92.29% | 63.39% | 50.68% | 35.66% |
Selling, General and Administrative Expense of Revenue |
56.55% | 31.02% | 54.99% | 19.69% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
37.85% | 9.22% | 59.20% | 18.77% |
Graham Net Nets |
(0.05) | (0.05) | 0.05 | 0.04 |
Graham Number |
0.00 | 6.47 | 0.00 | 15.54 |
Earnings Yield |
(1.14%) | (1.14%) | (1.30%) | 0.79% |
Free Cash Flow Yield |
(0.67%) | (0.67%) | 0.59% | 1.02% |
Revenue per Share |
2.34 | 3.12 | 3.02 | 5.12 |
Operating CF per Share |
(1.05) | (0.34) | 1.04 | 1.92 |
Capex per Share |
(0.11) | (0.07) | (0.26) | (0.23) |
Free Cash Flow per Share |
(1.16) | (0.42) | 0.78 | 1.69 |
Cash per Share |
4.77 | 4.02 | 6.97 | 7.14 |
Shareholders Equity per Share |
(2.50) | (2.63) | 7.35 | 8.19 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(2.50) | (2.63) | 7.35 | 8.19 |
Free Cash Flow |
(39.77) | (15.48) | 102.43 | 281.76 |
Working Capital |
165.92 | 150.73 | 926.44 | 1,228.99 |
Capital Expenditures |
(3.87) | (2.76) | (34.24) | (37.54) |
Net Current Asset Value |
(91.02) | (108.19) | 923.27 | 1,193.84 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 152.78 |
Capex to Sales |
0.05 | 0.02 | 0.09 | 0.04 |
Net Profit Margin |
(73.05%) | (22.68%) | (21.05%) | 25.70% |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 159.63 |
| Other line items | ||||
Depreciation/Fixed assets |
0.08 | 0.03 | (0.15) | (0.01) |
Cash ROIC |
(50.64%) | (33.77%) | 5.38% | 8.90% |
Accounts Receivable Turnover |
0.00 | 12.15 | 16.81 | 13.97 |
Accounts Payable Turnover |
0.00 | 4.33 | 5.63 | 5.98 |
Inventory Turnover |
0.00 | 1.36 | 2.78 | 4.06 |
Average Days of Payables |
177.32 | 64.31 | 104.98 | 74.60 |
Days of Inventory on Hand |
497.33 | 244.52 | 168.54 | 103.86 |
Average Receivables |
— | 9.53 | 23.57 | 61.01 |
Average Payables |
— | 8.32 | 16.63 | 34.64 |
Average Inventory |
— | 26.48 | 33.66 | 51.10 |
Average Assets |
— | 204.01 | 625.40 | 1,293.17 |
Average Common Equity |
— | (91.50) | 433.55 | 1,164.22 |
Columns are period end dates